phone icon  Int'l : +1-503-894-6022
0
Shopping Cart is Empty..
$ 0

Flow Cytometry Market

- Opportunities and Forecasts, 2012-2020
 Report Code: LI 1390
 Pages: 135
 Format: PDF Exel CD_rom
pub_n Published: Dec 2013
tab_nTables: 72
aut_nAuthor(s):

Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. Flow cytometry market was valued $3000 million in 2012, and is expected to reach a value of $6530 million by 2020, experiencing a CAGR of 30.9%. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches.

The key market players profiled in this report are BD Biosciences, Beckman Coulter, Merck Millipore, Amnis Corporation, Life Technologies Corporation, Luminex Corporation, Morphosys AG, eBiosciences Inc., Partec Gmbh and Advanced Analytical Technologies, Inc.

Fow cytometry market ready to take cell application to a new tangent

KEY BENEFITS

  • The report ranks the factors that are responsible to accelerate the market growth of flow cytometry
  • Market is forecasted for period of seven years from 2013 to 2020, with market revenues for 2 historic years  - 2011 and 2012
  • Identification and analysis of key investment pockets for flow cytometry market players
  • Identification of challenges that must be addressed and overcome in the flow cytometry market to achieve fiscal success throughout the market
  • The report identifies and profiles key market participants that would drive innovation in the flow cytometry market  

KEY MARKET SEGMENTSGLOBAL MARKET, BY PRODUCT

  • FC instruments
  • Reagents
  • Consumables
  • Software
  • Services
  • Accessories

GLOBAL MARKET, BY TECHNOLOGY

  • Cell based Technologies
  • Bead-based Technologies

GLOBAL MARKET, BY APPLICATION

  • Clinical
    • Apoptosis
    • Cell Cycle Analysis
    • Cell sorting
    • Cell Viability
  • Research Fields
    • Organ transplantation
    • Cancer
    • Immunodeficiency Disease
    • Hematology Haematological Malignancies

GLOBAL MARKET, BY END USERS

  • Commercial Organizations
  • Hospitals
  • Academic Institutes
  • Medical Schools
  • Clinical Testing Labs
  • Others

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW

KEY AUDIENCES

  • Clinical institutes
  • Research institutes
  • Pharma and biotech companies
  • Academic institutes
Table Of Contents
* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name Chapter Price

Chapter: 1 INTRODUCTION

1.1 Objective and Scope of the Report
1.2 Key Deliverables of the Report
1.3 Unique Benefits of the Report
1.4 Key Audiences
1.5 Research Methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

$0(SU) €0(SU) £0(SU)

Chapter: 2 EXECUTIVE SUMMARY

$195(SU) €0(SU) £0(SU)

Chapter: 3 GLOBAL FLOW CYTOMETRY MARKET OVERVIEW

3.1 Market Definition and Scope

3.1.1 Key applications of Flow cytometry
3.1.2 Application of Flow Cytometry in Gender Selection
3.1.3 Flow cytometry in Omics Technology

3.1.3.1 Applications of omics technology

3.1.3.1.1 Lung disease identification
3.1.3.1.2 Quantifying Abnormalities
3.1.3.1.3 Genetic Trait Diagnosis
3.1.3.1.4 Pharmacogenomics

3.1.4 Flow Cytometry in Immunophenotyping

3.1.4.1 Immunophenotyping in hematology applications

3.1.4.1.1 Erythrocyte analysis
3.1.4.1.2 Leukocyte Analysis
3.1.4.1.3 Platelet analysis

3.1.5 Flow cytometry in blood bank

3.1.6 Optimization of Flow Cytometry by Information Technology
3.1.7 Use Of Flow Cytometry In Resource-Poor Regions

 3.2 Top factors impacting Flow cytometry Market
 3.3 Top three winning strategies in the flow cytometry market

3.3.1 Product Launch
3.3.2 Agreement and Collaboration
3.3.3 Acquisition

3.4 Top investment pockets in flow cytometry market

3.4.1 Flow cytometry market- by clinical application
3.4.2 Flow cytometry market- by Research application
3.4.3 Flow cytometry market- by End users

3.5 Porter’s Five Forces Analysis

3.5.1 Intense Competition DecliningSupplier’s Power
3.5.2 Wide Range of Product Availability Enhances Buyer’s Power
3.5.3 Strategies to Be in Place to Combat Competition
3.5.4 High Investment Restricting Low Investment New Comers
3.5.5 Pricing Issues Impacting Adoption Rates

3.6 Reimbursement Scenario
3.7 Regulatory Issues

3.7.1 Challenges- in FDA Clearance
3.7.2 Impact of ASR Rule
3.7.3 Validation Challenges- Cell-Based
3.7.4 Validation Requirements (CLIA, CAP)
3.7.5 LDT Guidelines on Cell-based Fluorescence
3.7.6 Change in Regulations

3.8 Case studies

3.8.1 Case study 1: Expansion of the number of antibody conjugates
3.8.2 Case study 2: Recognition of target antibodies conjugates, Anti-human CD3: FITC.
3.8.3 Case study 3: To prove precursor B acute lymphoblastic leukemia has unusual transformation
3.8.4 Case study 4: To develop software that can run faster than the current flow cytometer software
3.8.5 Case study 5: To validate the mechanism of a candidate biologic drug

3.9 Market Dynamics

3.9.1 Drivers

3.9.1.1  Technological advancements
3.9.1.2 Clinical and research fields
3.9.1.3 Increase in scope of Applications areas
3.9.1.4 Investment in R&D
3.9.1.5 Increase in number of patients

3.9.2 RESTRAINTS

3.9.2.1 Instrument costs
3.9.2.2 Need of awareness
3.9.2.3 Need of trained personnel

3.9.3 OPPORTUNITIES 

3.9.3.1 In clinical approach
3.9.3.2 Research approach

$495(SU) €0(SU) £0(SU)

Chapter: 4 FLOW CYTOMETRY MARKET BY PRODUCT

4.1 Global flow cytometry market, by product type, 2012-2020, $million

4.1.1 Global flow cytometry Product market, by geography, 2012-2020, $million

4.2 Instruments

4.2.1 Global flow cytometry Product market ,by instruments, 2012-2020,$million
4.2.2 Global flow cytometry-instruments market, by geography, 2012-2020, $million
4.2.3 Key Market Drivers

4.2.3.1 Popularity of bench top flow cytometers
4.2.3.2 Technological trends

4.2.4 Platforms

4.2.4.1 Types of platforms

4.2.4.1.1 Single-Platform Approach

4.2.4.1.1.1 TYPES OF SINGLE PLATFORM

4.2.4.2 Global flow cytometry Product market, by platform, 2012-2020,$million
4.2.4.3 Global flow cytometry platform market, by geography, 2012-2020, $million
4.2.4.4 Sorters

4.2.4.4.1 Types of Sorters

4.2.4.5 Analysers

4.2.5 Replaceable Components

4.2.5.1 Drivers of Replaceable Components Market
4.2.5.2 Global flow cytometry replaceable components market, by types, 2012-2020, $million
4.2.5.3 Global flow cytometry replaceable components market, by geography, 2012-2020, $million
4.2.5.4 Filters

4.2.5.4.1 Types of filters
4.2.5.4.2 Global flow cytometry filters market, by geography, 2012-2020, $million

4.2.5.5 Lasers

4.2.5.5.1 Global flow cytometry lasers market, by geography, 2012-2020, $million

4.2.5.6 Detectors

4.2.5.6.1 Global flow cytometry detectors market, by geography, 2012-2020, $million

4.2.5.7 Others

4.2.5.7.1 Global flow cytometry other components market, by geography, 2012-2020, $million

4.2.6 Accessories

4.2.6.1 Global flow cytometry Accessories market, by geography, 2012-2020, $million

4.3 Reagents and Consumables

4.3.1 Drivers of Reagents and consumables market
4.3.2 Global flow cytometry reagents and consumables market, by type, 2012-2020, $million
4.3.3 Global flow cytometry reagents and consumables market, by geography, 2012-2020, $million
4.3.4 Antibodies

4.3.4.1 Global flow cytometry antibodies market, by geography, 2012-2020, $million

4.3.5 Dyes

4.3.5.1 Global flow cytometry dyes market, by geography, 2012-2020, $million

4.3.6 Beads

4.3.6.1 Global flow cytometry beads market, by geography, 2012-2020, $million

4.3.7 Others

4.3.7.1 Reagent kits
4.3.7.2 Beads
4.3.7.3 Solutions
4.3.7.4 Buffers
4.3.7.5 Global flow cytometry other reagents and consumables market, by geography, 2012-2020, $million

4.4 Software

4.4.1 Global flow cytometry market, by software, 2012-2020, $million
4.4.2 Global flow cytometry- software market, by geography, 2012-2020, $million
4.4.3 With-System Software

4.4.3.1 Global flow cytometry with system market, by geography, 2012-2020, $million

4.4.4 Third Party Software

4.4.4.1 Global flow cytometry- third party market, by geography, 2012-2020, $million

4.5 Services

4.5.1 Global flow cytometry services market, by geography, 2012-2020, $million

$695(SU) €0(SU) £0(SU)

Chapter: 5 FLOW CYTOMETRY MARKET BY TECHNOLOGY

5.1 Global flow cytometry market, by technology, 2012-2020, $million
5.2 Global flow cytometry- technology market, by geography, 2012-2020, $million
5.3 Bead-Based Flow cytometry

5.3.1 Drivers of Bead Based Flow Cytometry Market

5.3.1.1 Application in the field of  genomics
5.3.1.2 Application in the field of proteomics
5.3.1.3 High competitive edge

5.3.2 Global flow cytometry bead based market, by geography, 2012-2020, $million

5.4 Cell Based Flow Cytometers

5.4.1 Global flow cytometry cell based market, by geography, 2012-2020, $million

$795(SU) €0(SU) £0(SU)

Chapter: 6 FLOW CYTOMETRY MARKET BY APPLICATION

6.1 Drivers of the Flow Cytometry Application Market

6.1.1 Research funds
6.1.2 Need for management in disease control
6.1.3 Increase in flow cytometry end users

6.2 Restraints of the flow cytometry application market
6.3 Global flow cytometry market, by applications, 2012-2020, $million
6.4 Global flow cytometry-application market , by geography, 2012-2020, $million
6.5 Research Applications

6.5.1 Global flow cytometry market, by research applications, 2012-2020, $million
6.5.2 Global flow cytometry-research application market, by geography, 2012-2020, $million
6.5.3 Cell Cycle Analysis and Cell Proliferation

6.5.3.1 Global flow cytometry Cell cycle analysis and Cell proliferation market, by geography, 2012-2020, $million

6.5.4 Apoptosis

6.5.4.1 Drivers of Apoptosis market
6.5.4.2 Global flow cytometry Apoptosis market, by geography, 2012-2020, $million

6.5.5 Cell Sorting

6.5.5.1  Global flow cytometry Cell sorting market, by geography, 2012-2020, $million

6.5.6 Transfection and Cell Viability

6.5.6.1 Global flow cytometry Transfection and Cell viability market, by geography, 2012-2020, $million

6.5.7 Others

6.5.7.1 Global flow cytometry other research application market, by geography, 2012-2020, $million

6.6 Clinical Applications

6.6.1 Global flow cytometry market, by clinical applications, 2012-2020, $million
6.6.2 Global flow cytometry clinical application market, by geography, 2012-2020, $million
6.6.3 Organ Transplantation

6.6.3.1 Drivers of Organ transplantation market
6.6.3.2 Global flow cytometry organ transplant market, by geography, 2012-2020, $million

6.6.4 Hematology Hematological Malignancies

6.6.4.1 Global flow cytometry Hematology hematological malignancies market, by geography, 2012-2020, $million
6.6.4.2 Myeloma
6.6.4.3 Lymphomas
6.6.4.4 Leukemia

6.6.5 Cancer and Solid Tumour

6.6.5.1 Drivers of Cancer and solid tumor market
6.6.5.2 Restraints of Cancer and solid tumor market
6.6.5.3 Global flow cytometry Cancer and solid tumor market, by geography, 2012-2020, $million

6.6.6 Immunodeficiency Disease-HIV Infection

6.6.6.1 Key facts about HIV
6.6.6.2 Drivers of HIV market
6.6.6.3 Restraints of HIV market
6.6.6.4 Global flow cytometry Immunodeficiency disease-HIV infectionmarket, by geography, 2012-2020, $million

6.6.7 Others

6.6.7.1 Global flow cytometry other clinical application market, by geography, 2012-2020, $million

$1095(SU) €0(SU) £0(SU)

Chapter: 7 FLOW CYTOMETRY MARKET BY END USER

7.1 Global flow cytometry market, by end user, 2012-2020, $million
7.2 Global flow cytometry end user market, by geography, 2012-2020, $million
7.3 Commercial Organizations

7.3.1 Global flow cytometry commercial market, by geography, 2012-2020, $million

7.4 Medical Schools and Clinical Testing Labs

7.4.1 Global flow cytometry medical schools and clinical testing labs market, by geography, 2012-2020, $million

7.5 Hospitals

7.5.1 Global flow cytometry hospitals market, by geography, 2012-2020, $million

7.6 Academics

7.6.1 Global flow cytometry Academics market, by geography, 2012-2020, $million

7.7 Others

7.7.1 Global flow cytometry other end user market, by geography, 2012-2020, $million

$895(SU) €0(SU) £0(SU)

Chapter: 8 FLOW CYTOMETRY MARKET BY GEOGRAPHY

8.1 North America

8.1.1 Drivers of the North American Market
8.1.2 North American flow cytometry market, 2012-2020, $million

8.2 Europe

8.2.1 Drivers of the European market
8.2.2 European flow cytometry market, 2012-2020, $million

8.3 Asia Pacific and RoW

8.3.1 Asia and RoW flow cytometry market, 2012-2020, $million

$695(SU) €0(SU) £0(SU)

Chapter: 9 COMPANY PROFILES

9.1 Advanced Analytical Technologies, Inc (AATI)

9.1.1 Company Overview
9.1.2 Company Snapshot
9.1.3 Strategies and Development
9.1.4 Swot Analysis of Advanced Analytical Technologies

9.2 Merck Millipore

9.2.1 Company Overview
9.2.2 Company Snapshot
9.2.3 Business Performance
9.2.4 Strategies and Development

9.2.4.1 Primary strategies: Agreement
9.2.4.2 Other strategies

9.2.5 SwotAnalysis of Merck Millipore

9.3 Life Technologies Corporation

9.3.1 Company Overview
9.3.2 Company Snapshot
9.3.3 Business Performance
9.3.4 Strategies and Development

9.3.4.1 Primary Strategies: Agreement
9.3.4.2 Secondary Strategies: Launch and Acquisition

9.3.5 SwotAnalysis of Life Technologies Corporation.

9.4 Beckman Coulter, Inc.

9.4.1 Company overview
9.4.2 Company Snapshot
9.4.3 Strategies and Development

9.4.3.1 Primary strategies: product Launch
9.4.3.2 Secondary strategies: Agreement & acquisition

9.4.4 Swot Analysis OF Beckman Coulter, Inc.

9.5 Becton, Dickinson & Co.

9.5.1 Company Overview
9.5.2 Snapshot of Becton, Dickinson & CO.
9.5.3 Business Performance
9.5.4 Strategies and Development

9.5.4.1 Primary strategies: Launch
9.5.4.2 Other strategies

9.5.5 SWOT analysis of Becton, Dickinson & Co

9.6 Luminex Corporation

9.6.1 Company Overview
9.6.2 Snapshot
9.6.3 Business Performance
9.6.4 Strategies and Development

9.6.4.1 Primary strategies: Agreement
9.6.4.2 Other strategies

9.6.5 Swot Analysis of LUMINEX CORPORATION

9.7 AmnisCorporation

9.7.1 Company Overview
9.7.2 Snapshot
9.7.3 Strategies and Development

9.7.3.1 Primary strategies: Launch
9.7.3.2 Other strategies

9.7.4 SwotAnalysis of AmnisCorporation

9.8 Partec GmbH

9.8.1 Company Overview
9.8.2 Snapshot
9.8.3 Strategies and Development
9.8.4 SwotAnalysis of Partec GmbH

9.9 EBIOSCIENCE, Inc.

9.9.1 Company Overview
9.9.2 Snapshot
9.9.3 Business Performance
9.9.4 Strategies and Development

9.9.4.1 Primary strategies: launch
9.9.4.2 Other strategies

9.9.5 Swot Analysis of eBioscience, Inc.

9.10 MORPHOSYS AG

9.10.1 Company Overview
9.10.2 Snapshot
9.10.3 Business performance
9.10.4 Strategies and Development

9.10.4.1 Primary strategies: Agreement, Launch.
9.10.4.2 Other strategies

9.10.5 Swot Analysis of Morphosys AG

 

LIST OF TABLES:

TABLE 1 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 2 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT TYPE, 2012-2020, $MILLION
TABLE 3 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 4 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY, INSTRUMENTS, 2012-2020, $MILLION
TABLE 5 GLOBAL FLOW CYTOMETRY-INSTRUMENTS MARKET BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6 TYPES OF PLATFORM
TABLE 7 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY PLATFORMS, 2012-2020, MILLIONS
TABLE 8 GLOBAL FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9 TYPES OF SORTERS:
TABLE 10 GLOBAL FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 11 ANALYZERS BY KEY PLAYERS
TABLE 12 GLOBAL FLOW CYTOMETRY ANALYSERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 13 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY REPLACEABLE COMPONENTS MARKET, 2012-2020, $MILLION
TABLE 14 GLOBAL FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 15 TYPES OF FILTERS
TABLE 16 GLOBAL FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 17 GLOBAL FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18 TYPES OF DETECTORS
TABLE 19 GLOBAL FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20 GLOBAL FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 21 GLOBAL FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 22 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2012-2020, $MILLION
TABLE 23 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 24 GLOBAL FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25 GLOBAL FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26 GLOBAL FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27 GLOBAL FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28 GLOBAL FLOW CYTOMETRY MARKET , BY SOFTWARE, 2012-2020, $MILLION
TABLE 29 GLOBAL FLOW CYTOMETRY- SOFTWARE MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 30 GLOBAL FLOW CYTOMETRY WITH SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31 GLOBAL FLOW CYTOMETRY- THIRD PARTY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32 GLOBAL FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 34 GLOBAL FLOW CYTOMETRY- TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35 GLOBAL FLOW CYTOMETRY BEAD BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36 GLOBAL FLOW CYTOMETRY CELL BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 37 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATIONS, 2012-2020, $MILLION
TABLE 38 GLOBAL FLOW CYTOMETRY-APPLICATION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 39 GLOBAL FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2012-2020, $MILLION
TABLE 40 GLOBAL FLOW CYTOMETRY-RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 41 GLOBAL FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 42 GLOBAL FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 43 GLOBAL FLOW CYTOMETRY CELL SORTING MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 44 GLOBAL FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 45 GLOBAL FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 46 GLOBAL FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2012-2020, $MILLION
TABLE 47 GLOBAL FLOW CYTOMETRY CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 48 GLOBAL FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 49 GLOBAL FLOW CYTOMETRY HEMATOLOGY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 50 GLOBAL FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 51 GLOBAL FLOW CYTOMETRY IMMUNODEFICIENCY DISEASE-HIV INFECTION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 52 GLOBAL FLOW CYTOMETRY OTHER CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 53 GLOBAL FLOW CYTOMETRY MARKET, BY END USER, 2012-2020, $MILLION
TABLE 54 GLOBAL FLOW CYTOMETRY END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 55 GLOBAL FLOW CYTOMETRY COMMERCIAL MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 56 GLOBAL FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 57 GLOBAL FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 58 GLOBAL FLOW CYTOMETRY ACADEMICS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 59 GLOBAL FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 60 NORTH AMERICAN FLOW CYTOMETRY MARKET, 2012-2020, $MILLION
TABLE 61 EUROPEAN FLOW CYTOMETRY MARKET,2012-2020, $MILLION
TABLE 62 ASIA AND ROW FLOW CYTOMETRY MARKET, 2012-2020, $MILLION
TABLE 63 SNAPSHOT OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)
TABLE 64 SNAPSHOTOF MERCK MILLIPORE,
TABLE 65 SNAPSHOT OF LIFE TECHNOLOGIES CORPORATION
TABLE 66 SNAPSHOT OF BECKMAN COULTER, INC.
TABLE 67 SNAPSHOT OF BECTON DICKINSON
TABLE 68  SNAPSHOT OF LUMINEX CORPORATION
TABLE 69 SNAPSHOT OF AMNISCORPORATION
TABLE 70 SNAPSHOT OF PARTEC GMBH
TABLE 71 SNAPSHOT OF EBIOSCIENCE, INC.
TABLE 72 SNAPSHOT OF  MORPHOSYS AG


 
LIST OF FIGURES:

FIG. 1 FLOW CYTOMETRY MARKET DEFINITION
FIG. 2 TOP FACTORS IMPACTING FLOW CYTOMETRY MARKET(2013-2020)
FIG. 3 TOP THREE WINNING STRATEGIES OF FLOW CYTOMETRY MARKET (2010-2013)
FIG. 4 TOP INVESTMENT MARKETS BY CLINICAL APPLICATION
FIG. 5 TOP INVESTMENT MARKETS BY RESEARCH APPLICATION
FIG. 6 TOP INVESTMENT MARKETS BY END-USERS
FIG. 7 PORTER’S FIVE FORCE ANALYSIS
FIG. 8 TYPES OF PLATFORM
FIG. 9 NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2012)
FIG. 10 ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA, MYELOMA (2013)
FIG. 11 ESTIMATED NEW CASES AS PER TYPES OF LEUKEMIA (2013)
FIG. 12 ESTIMATED NEW CASES AND DEATHS IN U.S.  (2012)
FIG. 13 TOP TEN COUNTRIES IN CANCER POPULATION (PER 1, 00,000 PEOPLE) 2011
FIG. 14 POPULATION LIVING WITH HIV/AIDS (TOP TEN COUNTRIES) 2012
FIG. 15 ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES U.S (2013)
FIG. 16 SWOT ANALYSIS OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)
FIG. 17 FINANCIAL REVENUES OF MERCK MILLIPORE SALES BY BUSINESS UNIT (2012)
FIG. 18 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHIC AREAS (2012)
FIG. 19 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 20 FINANCIAL REVENUES BY END MARKETS (2012)
FIG. 21 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 22 SWOT ANALYSIS OF LIFE TECHNOLOGIES CORPORATION
FIG. 23 SWOT ANALYSIS OF BECKMAN COULTER, INC
FIG. 24 FINANCIAL REVENUES OF BECTON, DICKINSON & CO. BY GEOGRAPHIC AREAS (2012)
FIG. 25 FINANCIAL REVENUES OF BECTON, DICKINSON & CO. BY BUSINESS UNITS (2012)
FIG. 26 SWOT ANALYSIS OF BECTON, DICKINSON & CO
FIG. 27 REVENUE BY SALES TO CUSTOMERS (2012)
FIG. 28 SWOT ANALYSIS OF LUMINEX CORPORATION
FIG. 29 SWOT ANALYSIS OF AMNIS CORPORATION
FIG. 30 SWOT ANALYSIS OF PARTEC GMBH
FIG. 31 SWOT ANALYSIS OF EBIOSCIENCE, INC
FIG. 32 FINANCIAL REVENUES OF MORPHOSYS AG BY BUSINESS UNITS (2012)
FIG. 33 FINANCIAL REVENUES OF  MORPHOSYS AG BY GEOGRAPHIC AREAS (2012)
FIG. 34 SWOT ANALYSIS OF MORPHOSYS AG

$795(SU) €0(SU) £0(SU)

Flow cytometer is a high throughput measurement technology, which does large variety of cell level measurements from cell counting to quantification of proteins. Comparing to the last decade the speed and accuracy of this technology has increased. Previously only few samples could be analyzed in a certain period of time but nowadays many samples can be analyzed simultaneously using this technology. Complex analysis offered by flow cytometry allows analysis of various cell signaling and phenotypes of stem cells. This technology has the capabilities to conjugate antibodies to bio molecules, dyes, linkers, drugs, etc. Flow cytometer is also capable of measuring six markers and can produce 3 million data points from single patient. Cell based flow cytometry is commonly used for measurement and diagnosis in blood cancer.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User
$4515
Group User
$5325
Site User
$7350
Global User
$10680
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    Medical tourism can be broadly defined as travel across international borders with the purpose of availing medical treatment, which may or may not be available in one’s own country. This treatment may include a wide array of medical services; however, the most frequently availed services include, cancer treatment, orthopedic treatment, elective surgery, and fertility treatment.
    Apr 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications.
    Jul 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart.
    Aug 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Cardiovascular diseases (CVD) are one of the foremost public health challenge across the globe. According to World Organization (WHO) estimate, about 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. Around one third of CVD deaths take place in the low and middle income countries. By the year 2030, more than 23 million people are likely to die annually from cardiovascular diseases.
    Jun 2016 | View Details >>
  • ...
    Peripheral vascular disease is a blood circulation disorder, which reduces the flow of blood through blood vessels located outside the heart and brain. When these vessels do not supply sufficient blood, it results in the abnormal functioning of organs. Peripheral vascular device are used to measure blood flow from arteries and veins. Peripheral vascular device would be in demand due to its minimally invasive endovascular treatment, rising prevalence of diseases such as diabetes & obesity and growing aging population.
    Jun 2016 | View Details >>
  • ...
    Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the performance of materials in use.
    Jun 2016 | View Details >>